Delivery Order SPE2DB20D2104-SPE2DB25FMRBM

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.94 contract is for the supply of the drug KERENDIA 10 MG TABLET 30S, with a period of performance through April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $4,782.77 and a period of performance through May 14, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,913.71, is a delivery order for the supply of the pharmaceutical product KERENDIA 10 MG TABLET 30S. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,869.73, is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $3,165.03 and a completion date of March 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,669.83, is for the delivery of Kerendia 10 mg tablet medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of the drug Kerendia 10 mg tablets, with a ceiling value of $3,508.65 and a completion date of August 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,293.50 firm fixed-price delivery order is for the supply of the drug KERENDIA 10 MG TABLET 30S. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90-count bottles of the pharmaceutical product KERENDIA 10 MG TABLET. The contract has a completion date of March 8, 2024 and a potential value of $1,695.53. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,380.41, is for the delivery of the medication KERENDIA 10 MG TABLET 30S. The contract is a Firm Fixed Price type and has a period of performance through March 29, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMRBM
    Delivery Order

This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the medication KERENDIA 10 MG TABLET 30S. The contract has a ceiling value of $3,320.59 and a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA, U.S. Coast Guard, and other government customers. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 8/17/25, 12:56 AM